Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Biessels, G.-J.
Right arrow Articles by Gispen, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biessels, G.-J.
Right arrow Articles by Gispen, W. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 122, No. 4, 757-768, April 1999
© 1999 Oxford University Press

Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats

Course of development and effects of insulin treatment

Geert-Jan Biessels1,2, Nuno A. Cristino1, Geert-Jan Rutten1, Frank P. T. Hamers1, D. Willem Erkelens3 and Willem Hendrik Gispen1

1 Department of Medical Pharmacology, Rudolf Magnus Institute for Neurosciences, Utrecht University and Departments of 2 Neurology and 3 Internal Medicine, University Hospital, Utrecht, The Netherlands

Correspondence to: Dr G. Biessels, Department of Neurology, University Hospital Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands

Diabetes mellitus can affect both the peripheral and the central nervous system. However, central deficits are documented less well than peripheral deficits. We therefore compared the course of development of neurophysiological changes in the central and peripheral nervous systems in streptozotocin-diabetic rats. Sciatic nerve conduction velocities and auditory and visual evoked potentials were measured prior to diabetes induction, and then monthly after diabetes induction for 6 months. In addition, the effect of insulin treatment was examined. Treatment was initiated after a diabetes duration of 6 months and was continued for 3 months. During treatment, evoked potentials and nerve conduction were measured monthly. In a third experiment, conduction velocities in ascending and descending pathways of the spinal cord were examined after 3 and 6 months of diabetes. Impairments of sciatic nerve conduction velocities developed fully during the first 2–3 months of diabetes. In contrast, increased latencies of auditory and visual evoked potentials developed only after 3–4 months of diabetes, and progressed gradually thereafter. Insulin treatment, initiated 6 months after induction of diabetes, improved both nerve conduction velocities and evoked potential latencies. Conduction velocities in the spinal cord tended to be reduced after 3 months of diabetes and were significantly reduced after 6 months of diabetes. The present study demonstrates that in streptozotocin-diabetic rats the course of development of peripheral and central neurophysiological changes differs. Peripheral impairments develop within weeks after diabetes induction, whereas central impairments take months to develop. Insulin can reverse both peripheral and central neurophysiological alterations.

diabetes mellitus; evoked potentials; nerve conduction; spinal cord; insulin

ANOVA = analysis of variance; ANOVAR = analysis of variance for repeated measurements; BAEP = brainstem auditory evoked potential; MNCV = motor nerve conduction velocity; SNCV = sensory nerve conduction velocity; STZ = streptozotocin; VEP = visual evoked potential


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. M. Lechuga-Sancho, A. I. Arroba, L. M. Frago, C. Garcia-Caceres, A. D.-R. de Celix, J. Argente, and J. A. Chowen
Reduction in the Number of Astrocytes and Their Projections Is Associated with Increased Synaptic Protein Density in the Hypothalamus of Poorly Controlled Diabetic Rats
Endocrinology, November 1, 2006; 147(11): 5314 - 5324.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Price, C. Dent, B. Duran-Jimenez, Y. Liang, L. Zhang, E. J. Rebar, C. C. Case, P. D. Gregory, T. J. Martin, S. K. Spratt, et al.
Gene Transfer of an Engineered Transcription Factor Promoting Expression of VEGF-A Protects Against Experimental Diabetic Neuropathy
Diabetes, June 1, 2006; 55(6): 1847 - 1854.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. A.F. Sima and Z.-g. Li
The Effect of C-Peptide on Cognitive Dysfunction and Hippocampal Apoptosis in Type 1 Diabetic Rats
Diabetes, May 1, 2005; 54(5): 1497 - 1505.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. Verrotti, T. Giuva, G. Morgese, and F. Chiarelli
Topical Review : New Trends in the Etiopathogenesis of Diabetic Peripheral Neuropathy
J Child Neurol, June 1, 2001; 16(6): 389 - 394.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.